nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP1A2—Imiquimod—skin cancer	0.0944	0.153	CbGbCtD
Mirtazapine—CYP2C8—Vismodegib—skin cancer	0.0845	0.137	CbGbCtD
Mirtazapine—CYP2C9—Vismodegib—skin cancer	0.0589	0.0958	CbGbCtD
Mirtazapine—CYP1A2—Vemurafenib—skin cancer	0.0517	0.084	CbGbCtD
Mirtazapine—CYP3A4—Imiquimod—skin cancer	0.0494	0.0803	CbGbCtD
Mirtazapine—CYP3A4—Temozolomide—skin cancer	0.0494	0.0803	CbGbCtD
Mirtazapine—CYP2D6—Vemurafenib—skin cancer	0.0426	0.0692	CbGbCtD
Mirtazapine—CYP1A2—Dacarbazine—skin cancer	0.0396	0.0644	CbGbCtD
Mirtazapine—CYP3A4—Vismodegib—skin cancer	0.0343	0.0557	CbGbCtD
Mirtazapine—CYP2C8—Fluorouracil—skin cancer	0.03	0.0488	CbGbCtD
Mirtazapine—CYP3A4—Vemurafenib—skin cancer	0.0271	0.044	CbGbCtD
Mirtazapine—CYP1A2—Fluorouracil—skin cancer	0.0232	0.0378	CbGbCtD
Mirtazapine—CYP2C9—Fluorouracil—skin cancer	0.0209	0.034	CbGbCtD
Mirtazapine—CYP3A4—Docetaxel—skin cancer	0.0093	0.0151	CbGbCtD
Mirtazapine—HRH1—nose—skin cancer	0.00507	0.0837	CbGeAlD
Mirtazapine—HTR3A—nerve—skin cancer	0.00301	0.0497	CbGeAlD
Mirtazapine—SLC6A3—nerve—skin cancer	0.0025	0.0413	CbGeAlD
Mirtazapine—SLC6A2—nerve—skin cancer	0.00202	0.0333	CbGeAlD
Mirtazapine—HTR2A—hindlimb—skin cancer	0.002	0.033	CbGeAlD
Mirtazapine—HTR7—nerve—skin cancer	0.00195	0.0321	CbGeAlD
Mirtazapine—DRD2—nerve—skin cancer	0.00184	0.0304	CbGeAlD
Mirtazapine—HTR2A—appendage—skin cancer	0.00171	0.0283	CbGeAlD
Mirtazapine—HTR7—endothelium—skin cancer	0.00166	0.0274	CbGeAlD
Mirtazapine—HTR7—blood vessel—skin cancer	0.00153	0.0252	CbGeAlD
Mirtazapine—HRH3—head—skin cancer	0.00149	0.0246	CbGeAlD
Mirtazapine—HTR2A—nerve—skin cancer	0.00121	0.02	CbGeAlD
Mirtazapine—OPRK1—female reproductive system—skin cancer	0.0011	0.0182	CbGeAlD
Mirtazapine—HTR7—neck—skin cancer	0.00109	0.0181	CbGeAlD
Mirtazapine—HTR2A—endothelium—skin cancer	0.00103	0.0171	CbGeAlD
Mirtazapine—DRD3—head—skin cancer	0.00103	0.017	CbGeAlD
Mirtazapine—ADRA2C—nipple—skin cancer	0.00102	0.0168	CbGeAlD
Mirtazapine—ADRB1—connective tissue—skin cancer	0.000956	0.0158	CbGeAlD
Mirtazapine—HTR2A—blood vessel—skin cancer	0.000953	0.0157	CbGeAlD
Mirtazapine—OPRK1—head—skin cancer	0.00092	0.0152	CbGeAlD
Mirtazapine—CYP1A2—nipple—skin cancer	0.000882	0.0145	CbGeAlD
Mirtazapine—HTR2B—skin of body—skin cancer	0.000827	0.0136	CbGeAlD
Mirtazapine—HRH1—nipple—skin cancer	0.000825	0.0136	CbGeAlD
Mirtazapine—ADRA2A—nipple—skin cancer	0.000811	0.0134	CbGeAlD
Mirtazapine—HTR7—connective tissue—skin cancer	0.000784	0.0129	CbGeAlD
Mirtazapine—HTR7—epithelium—skin cancer	0.000744	0.0123	CbGeAlD
Mirtazapine—ADRA1A—epithelium—skin cancer	0.000718	0.0118	CbGeAlD
Mirtazapine—HTR3A—head—skin cancer	0.000714	0.0118	CbGeAlD
Mirtazapine—HTR2C—female reproductive system—skin cancer	0.000687	0.0113	CbGeAlD
Mirtazapine—HTR2A—neck—skin cancer	0.000682	0.0113	CbGeAlD
Mirtazapine—ADRB1—female reproductive system—skin cancer	0.000674	0.0111	CbGeAlD
Mirtazapine—SLC6A4—female reproductive system—skin cancer	0.000652	0.0108	CbGeAlD
Mirtazapine—HTR2B—female reproductive system—skin cancer	0.000646	0.0107	CbGeAlD
Mirtazapine—SLC6A3—head—skin cancer	0.000594	0.0098	CbGeAlD
Mirtazapine—ADRA2C—mammalian vulva—skin cancer	0.000593	0.00979	CbGeAlD
Mirtazapine—HRH1—connective tissue—skin cancer	0.000585	0.00966	CbGeAlD
Mirtazapine—ADRA2A—connective tissue—skin cancer	0.000575	0.00949	CbGeAlD
Mirtazapine—HTR2C—head—skin cancer	0.000574	0.00948	CbGeAlD
Mirtazapine—SLC6A2—female reproductive system—skin cancer	0.000574	0.00947	CbGeAlD
Mirtazapine—ADRB1—head—skin cancer	0.000563	0.0093	CbGeAlD
Mirtazapine—HRH1—epithelium—skin cancer	0.000556	0.00917	CbGeAlD
Mirtazapine—ADRA1A—lymphoid tissue—skin cancer	0.000553	0.00912	CbGeAlD
Mirtazapine—HTR7—female reproductive system—skin cancer	0.000553	0.00912	CbGeAlD
Mirtazapine—SLC6A4—head—skin cancer	0.000544	0.00898	CbGeAlD
Mirtazapine—HTR2B—head—skin cancer	0.000539	0.0089	CbGeAlD
Mirtazapine—HTR2A—connective tissue—skin cancer	0.000489	0.00807	CbGeAlD
Mirtazapine—HTR1A—head—skin cancer	0.000483	0.00798	CbGeAlD
Mirtazapine—HRH1—mammalian vulva—skin cancer	0.000482	0.00796	CbGeAlD
Mirtazapine—SLC6A2—head—skin cancer	0.000479	0.00791	CbGeAlD
Mirtazapine—ADRA2A—mammalian vulva—skin cancer	0.000473	0.00781	CbGeAlD
Mirtazapine—CYP2C8—female reproductive system—skin cancer	0.000471	0.00778	CbGeAlD
Mirtazapine—HTR2A—epithelium—skin cancer	0.000464	0.00766	CbGeAlD
Mirtazapine—HTR7—head—skin cancer	0.000462	0.00762	CbGeAlD
Mirtazapine—ADRA1A—head—skin cancer	0.000446	0.00735	CbGeAlD
Mirtazapine—DRD2—head—skin cancer	0.000437	0.00721	CbGeAlD
Mirtazapine—ADRA2C—head—skin cancer	0.000425	0.00701	CbGeAlD
Mirtazapine—CYP2C9—female reproductive system—skin cancer	0.000419	0.00691	CbGeAlD
Mirtazapine—HRH1—female reproductive system—skin cancer	0.000413	0.00681	CbGeAlD
Mirtazapine—ADRA2A—female reproductive system—skin cancer	0.000405	0.00669	CbGeAlD
Mirtazapine—HTR2B—lymph node—skin cancer	0.000378	0.00623	CbGeAlD
Mirtazapine—HRH1—head—skin cancer	0.000345	0.00569	CbGeAlD
Mirtazapine—HTR2A—female reproductive system—skin cancer	0.000345	0.00569	CbGeAlD
Mirtazapine—ADRA2A—head—skin cancer	0.000339	0.00559	CbGeAlD
Mirtazapine—SLC6A2—lymph node—skin cancer	0.000336	0.00554	CbGeAlD
Mirtazapine—Hypoaesthesia—Fluorouracil—skin cancer	0.000335	0.0012	CcSEcCtD
Mirtazapine—Pharyngitis—Fluorouracil—skin cancer	0.000334	0.0012	CcSEcCtD
Mirtazapine—Angiopathy—Temozolomide—skin cancer	0.000332	0.00119	CcSEcCtD
Mirtazapine—Ataxia—Docetaxel—skin cancer	0.00033	0.00119	CcSEcCtD
Mirtazapine—Cough—Bleomycin—skin cancer	0.000329	0.00118	CcSEcCtD
Mirtazapine—Chills—Temozolomide—skin cancer	0.000328	0.00118	CcSEcCtD
Mirtazapine—Dehydration—Docetaxel—skin cancer	0.000327	0.00117	CcSEcCtD
Mirtazapine—Ill-defined disorder—Dactinomycin—skin cancer	0.000326	0.00117	CcSEcCtD
Mirtazapine—Anaemia—Dactinomycin—skin cancer	0.000325	0.00117	CcSEcCtD
Mirtazapine—Liver function test abnormal—Docetaxel—skin cancer	0.000324	0.00116	CcSEcCtD
Mirtazapine—Vomiting—Vemurafenib—skin cancer	0.000323	0.00116	CcSEcCtD
Mirtazapine—Alopecia—Temozolomide—skin cancer	0.000323	0.00116	CcSEcCtD
Mirtazapine—Dry skin—Docetaxel—skin cancer	0.000322	0.00116	CcSEcCtD
Mirtazapine—Chest pain—Bleomycin—skin cancer	0.000321	0.00115	CcSEcCtD
Mirtazapine—Myalgia—Bleomycin—skin cancer	0.000321	0.00115	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Docetaxel—skin cancer	0.000321	0.00115	CcSEcCtD
Mirtazapine—Rash—Vemurafenib—skin cancer	0.00032	0.00115	CcSEcCtD
Mirtazapine—Mental disorder—Temozolomide—skin cancer	0.00032	0.00115	CcSEcCtD
Mirtazapine—Dermatitis—Vemurafenib—skin cancer	0.00032	0.00115	CcSEcCtD
Mirtazapine—Hypersensitivity—Imiquimod—skin cancer	0.000319	0.00115	CcSEcCtD
Mirtazapine—CYP3A4—female reproductive system—skin cancer	0.000319	0.00527	CbGeAlD
Mirtazapine—Headache—Vemurafenib—skin cancer	0.000318	0.00114	CcSEcCtD
Mirtazapine—Malnutrition—Temozolomide—skin cancer	0.000318	0.00114	CcSEcCtD
Mirtazapine—Discomfort—Bleomycin—skin cancer	0.000317	0.00114	CcSEcCtD
Mirtazapine—Malaise—Dactinomycin—skin cancer	0.000317	0.00114	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000316	0.00114	CcSEcCtD
Mirtazapine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000316	0.00114	CcSEcCtD
Mirtazapine—Leukopenia—Dactinomycin—skin cancer	0.000315	0.00113	CcSEcCtD
Mirtazapine—CYP2D6—female reproductive system—skin cancer	0.000314	0.00518	CbGeAlD
Mirtazapine—Dysgeusia—Temozolomide—skin cancer	0.000312	0.00112	CcSEcCtD
Mirtazapine—Asthenia—Imiquimod—skin cancer	0.000311	0.00112	CcSEcCtD
Mirtazapine—Confusional state—Bleomycin—skin cancer	0.00031	0.00111	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00031	0.00111	CcSEcCtD
Mirtazapine—Oedema—Bleomycin—skin cancer	0.000308	0.0011	CcSEcCtD
Mirtazapine—Back pain—Temozolomide—skin cancer	0.000308	0.0011	CcSEcCtD
Mirtazapine—Pruritus—Imiquimod—skin cancer	0.000307	0.0011	CcSEcCtD
Mirtazapine—Infection—Bleomycin—skin cancer	0.000306	0.0011	CcSEcCtD
Mirtazapine—Nausea—Vemurafenib—skin cancer	0.000302	0.00108	CcSEcCtD
Mirtazapine—Thrombocytopenia—Bleomycin—skin cancer	0.000301	0.00108	CcSEcCtD
Mirtazapine—Arrhythmia—Fluorouracil—skin cancer	0.000301	0.00108	CcSEcCtD
Mirtazapine—Myalgia—Dactinomycin—skin cancer	0.0003	0.00107	CcSEcCtD
Mirtazapine—Tremor—Temozolomide—skin cancer	0.000298	0.00107	CcSEcCtD
Mirtazapine—Alopecia—Fluorouracil—skin cancer	0.000298	0.00107	CcSEcCtD
Mirtazapine—ADRA2C—lymph node—skin cancer	0.000297	0.00491	CbGeAlD
Mirtazapine—Diarrhoea—Imiquimod—skin cancer	0.000297	0.00106	CcSEcCtD
Mirtazapine—Discomfort—Dactinomycin—skin cancer	0.000296	0.00106	CcSEcCtD
Mirtazapine—Angina pectoris—Docetaxel—skin cancer	0.000296	0.00106	CcSEcCtD
Mirtazapine—Ill-defined disorder—Temozolomide—skin cancer	0.000295	0.00106	CcSEcCtD
Mirtazapine—Anaemia—Temozolomide—skin cancer	0.000294	0.00106	CcSEcCtD
Mirtazapine—Anorexia—Bleomycin—skin cancer	0.000293	0.00105	CcSEcCtD
Mirtazapine—Agitation—Temozolomide—skin cancer	0.000292	0.00105	CcSEcCtD
Mirtazapine—Pancytopenia—Docetaxel—skin cancer	0.000288	0.00104	CcSEcCtD
Mirtazapine—HTR2A—head—skin cancer	0.000288	0.00475	CbGeAlD
Mirtazapine—Hypotension—Bleomycin—skin cancer	0.000288	0.00103	CcSEcCtD
Mirtazapine—Oedema—Dactinomycin—skin cancer	0.000287	0.00103	CcSEcCtD
Mirtazapine—Malaise—Temozolomide—skin cancer	0.000287	0.00103	CcSEcCtD
Mirtazapine—Dizziness—Imiquimod—skin cancer	0.000287	0.00103	CcSEcCtD
Mirtazapine—Vertigo—Temozolomide—skin cancer	0.000286	0.00103	CcSEcCtD
Mirtazapine—Infection—Dactinomycin—skin cancer	0.000285	0.00102	CcSEcCtD
Mirtazapine—Leukopenia—Temozolomide—skin cancer	0.000285	0.00102	CcSEcCtD
Mirtazapine—Neutropenia—Docetaxel—skin cancer	0.000284	0.00102	CcSEcCtD
Mirtazapine—Palpitations—Temozolomide—skin cancer	0.000281	0.00101	CcSEcCtD
Mirtazapine—Thrombocytopenia—Dactinomycin—skin cancer	0.000281	0.00101	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00028	0.00101	CcSEcCtD
Mirtazapine—Cough—Temozolomide—skin cancer	0.000278	0.000996	CcSEcCtD
Mirtazapine—Paraesthesia—Bleomycin—skin cancer	0.000276	0.000992	CcSEcCtD
Mirtazapine—Weight increased—Docetaxel—skin cancer	0.000276	0.000992	CcSEcCtD
Mirtazapine—Convulsion—Temozolomide—skin cancer	0.000276	0.000989	CcSEcCtD
Mirtazapine—Vomiting—Imiquimod—skin cancer	0.000276	0.000989	CcSEcCtD
Mirtazapine—Weight decreased—Docetaxel—skin cancer	0.000275	0.000986	CcSEcCtD
Mirtazapine—Hypertension—Temozolomide—skin cancer	0.000275	0.000986	CcSEcCtD
Mirtazapine—Dyspnoea—Bleomycin—skin cancer	0.000274	0.000985	CcSEcCtD
Mirtazapine—Anorexia—Dactinomycin—skin cancer	0.000274	0.000982	CcSEcCtD
Mirtazapine—Rash—Imiquimod—skin cancer	0.000273	0.000981	CcSEcCtD
Mirtazapine—Dermatitis—Imiquimod—skin cancer	0.000273	0.00098	CcSEcCtD
Mirtazapine—Pneumonia—Docetaxel—skin cancer	0.000272	0.000977	CcSEcCtD
Mirtazapine—Headache—Imiquimod—skin cancer	0.000271	0.000974	CcSEcCtD
Mirtazapine—Anaemia—Fluorouracil—skin cancer	0.000271	0.000972	CcSEcCtD
Mirtazapine—Arthralgia—Temozolomide—skin cancer	0.000271	0.000972	CcSEcCtD
Mirtazapine—Myalgia—Temozolomide—skin cancer	0.000271	0.000972	CcSEcCtD
Mirtazapine—Anxiety—Temozolomide—skin cancer	0.00027	0.000969	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000269	0.000965	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000268	0.000963	CcSEcCtD
Mirtazapine—Discomfort—Temozolomide—skin cancer	0.000268	0.000961	CcSEcCtD
Mirtazapine—Decreased appetite—Bleomycin—skin cancer	0.000268	0.00096	CcSEcCtD
Mirtazapine—Acute coronary syndrome—Docetaxel—skin cancer	0.000267	0.000958	CcSEcCtD
Mirtazapine—Myocardial infarction—Docetaxel—skin cancer	0.000265	0.000953	CcSEcCtD
Mirtazapine—Dry mouth—Temozolomide—skin cancer	0.000265	0.000951	CcSEcCtD
Mirtazapine—Stomatitis—Docetaxel—skin cancer	0.000264	0.000947	CcSEcCtD
Mirtazapine—Jaundice—Docetaxel—skin cancer	0.000264	0.000947	CcSEcCtD
Mirtazapine—Pain—Bleomycin—skin cancer	0.000263	0.000945	CcSEcCtD
Mirtazapine—Conjunctivitis—Docetaxel—skin cancer	0.000263	0.000945	CcSEcCtD
Mirtazapine—Leukopenia—Fluorouracil—skin cancer	0.000262	0.000942	CcSEcCtD
Mirtazapine—CYP2D6—head—skin cancer	0.000262	0.00433	CbGeAlD
Mirtazapine—Confusional state—Temozolomide—skin cancer	0.000262	0.00094	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000262	0.000939	CcSEcCtD
Mirtazapine—Oedema—Temozolomide—skin cancer	0.00026	0.000932	CcSEcCtD
Mirtazapine—Infection—Temozolomide—skin cancer	0.000258	0.000926	CcSEcCtD
Mirtazapine—Nausea—Imiquimod—skin cancer	0.000257	0.000924	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Docetaxel—skin cancer	0.000256	0.000919	CcSEcCtD
Mirtazapine—Epistaxis—Docetaxel—skin cancer	0.000255	0.000917	CcSEcCtD
Mirtazapine—Nervous system disorder—Temozolomide—skin cancer	0.000255	0.000914	CcSEcCtD
Mirtazapine—Thrombocytopenia—Temozolomide—skin cancer	0.000254	0.000912	CcSEcCtD
Mirtazapine—Convulsion—Fluorouracil—skin cancer	0.000254	0.000912	CcSEcCtD
Mirtazapine—Feeling abnormal—Bleomycin—skin cancer	0.000254	0.00091	CcSEcCtD
Mirtazapine—Agranulocytosis—Docetaxel—skin cancer	0.000253	0.000907	CcSEcCtD
Mirtazapine—Skin disorder—Temozolomide—skin cancer	0.000252	0.000905	CcSEcCtD
Mirtazapine—Hyperhidrosis—Temozolomide—skin cancer	0.000251	0.000901	CcSEcCtD
Mirtazapine—Myalgia—Fluorouracil—skin cancer	0.00025	0.000896	CcSEcCtD
Mirtazapine—Chest pain—Fluorouracil—skin cancer	0.00025	0.000896	CcSEcCtD
Mirtazapine—Decreased appetite—Dactinomycin—skin cancer	0.00025	0.000896	CcSEcCtD
Mirtazapine—Fatigue—Dactinomycin—skin cancer	0.000248	0.000888	CcSEcCtD
Mirtazapine—Anorexia—Temozolomide—skin cancer	0.000248	0.000888	CcSEcCtD
Mirtazapine—Discomfort—Fluorouracil—skin cancer	0.000247	0.000885	CcSEcCtD
Mirtazapine—Pain—Dactinomycin—skin cancer	0.000246	0.000881	CcSEcCtD
Mirtazapine—Urticaria—Bleomycin—skin cancer	0.000245	0.000878	CcSEcCtD
Mirtazapine—Rhinitis—Docetaxel—skin cancer	0.000244	0.000875	CcSEcCtD
Mirtazapine—Body temperature increased—Bleomycin—skin cancer	0.000243	0.000873	CcSEcCtD
Mirtazapine—Hepatitis—Docetaxel—skin cancer	0.000243	0.000872	CcSEcCtD
Mirtazapine—Hypoaesthesia—Docetaxel—skin cancer	0.000242	0.000868	CcSEcCtD
Mirtazapine—HRH1—lymph node—skin cancer	0.000241	0.00399	CbGeAlD
Mirtazapine—Confusional state—Fluorouracil—skin cancer	0.000241	0.000866	CcSEcCtD
Mirtazapine—Pharyngitis—Docetaxel—skin cancer	0.000241	0.000866	CcSEcCtD
Mirtazapine—Urinary tract disorder—Docetaxel—skin cancer	0.00024	0.000861	CcSEcCtD
Mirtazapine—Oedema peripheral—Docetaxel—skin cancer	0.000239	0.000859	CcSEcCtD
Mirtazapine—Oedema—Fluorouracil—skin cancer	0.000239	0.000859	CcSEcCtD
Mirtazapine—Urethral disorder—Docetaxel—skin cancer	0.000238	0.000855	CcSEcCtD
Mirtazapine—Infection—Fluorouracil—skin cancer	0.000238	0.000853	CcSEcCtD
Mirtazapine—ADRA2A—lymph node—skin cancer	0.000237	0.00391	CbGeAlD
Mirtazapine—Feeling abnormal—Dactinomycin—skin cancer	0.000237	0.000849	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000237	0.000849	CcSEcCtD
Mirtazapine—Insomnia—Temozolomide—skin cancer	0.000235	0.000843	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000235	0.000843	CcSEcCtD
Mirtazapine—Nervous system disorder—Fluorouracil—skin cancer	0.000235	0.000842	CcSEcCtD
Mirtazapine—Thrombocytopenia—Fluorouracil—skin cancer	0.000234	0.000841	CcSEcCtD
Mirtazapine—Tachycardia—Fluorouracil—skin cancer	0.000234	0.000838	CcSEcCtD
Mirtazapine—Paraesthesia—Temozolomide—skin cancer	0.000233	0.000837	CcSEcCtD
Mirtazapine—Dyspnoea—Temozolomide—skin cancer	0.000232	0.000831	CcSEcCtD
Mirtazapine—Somnolence—Temozolomide—skin cancer	0.000231	0.000829	CcSEcCtD
Mirtazapine—Erythema multiforme—Docetaxel—skin cancer	0.00023	0.000825	CcSEcCtD
Mirtazapine—Dyspepsia—Temozolomide—skin cancer	0.000229	0.00082	CcSEcCtD
Mirtazapine—Anorexia—Fluorouracil—skin cancer	0.000228	0.000818	CcSEcCtD
Mirtazapine—Eye disorder—Docetaxel—skin cancer	0.000227	0.000815	CcSEcCtD
Mirtazapine—Abdominal pain—Dactinomycin—skin cancer	0.000227	0.000815	CcSEcCtD
Mirtazapine—Body temperature increased—Dactinomycin—skin cancer	0.000227	0.000815	CcSEcCtD
Mirtazapine—Hypersensitivity—Bleomycin—skin cancer	0.000227	0.000814	CcSEcCtD
Mirtazapine—Decreased appetite—Temozolomide—skin cancer	0.000226	0.00081	CcSEcCtD
Mirtazapine—Cardiac disorder—Docetaxel—skin cancer	0.000226	0.00081	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000224	0.000805	CcSEcCtD
Mirtazapine—Fatigue—Temozolomide—skin cancer	0.000224	0.000803	CcSEcCtD
Mirtazapine—Hypotension—Fluorouracil—skin cancer	0.000224	0.000802	CcSEcCtD
Mirtazapine—Constipation—Temozolomide—skin cancer	0.000222	0.000797	CcSEcCtD
Mirtazapine—Pain—Temozolomide—skin cancer	0.000222	0.000797	CcSEcCtD
Mirtazapine—Asthenia—Bleomycin—skin cancer	0.000221	0.000793	CcSEcCtD
Mirtazapine—Angiopathy—Docetaxel—skin cancer	0.000221	0.000791	CcSEcCtD
Mirtazapine—Chills—Docetaxel—skin cancer	0.000218	0.000783	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000218	0.000782	CcSEcCtD
Mirtazapine—Pruritus—Bleomycin—skin cancer	0.000218	0.000782	CcSEcCtD
Mirtazapine—Arrhythmia—Docetaxel—skin cancer	0.000217	0.000779	CcSEcCtD
Mirtazapine—Insomnia—Fluorouracil—skin cancer	0.000216	0.000777	CcSEcCtD
Mirtazapine—Paraesthesia—Fluorouracil—skin cancer	0.000215	0.000771	CcSEcCtD
Mirtazapine—Alopecia—Docetaxel—skin cancer	0.000215	0.000771	CcSEcCtD
Mirtazapine—Feeling abnormal—Temozolomide—skin cancer	0.000214	0.000768	CcSEcCtD
Mirtazapine—Dyspnoea—Fluorouracil—skin cancer	0.000213	0.000766	CcSEcCtD
Mirtazapine—Mental disorder—Docetaxel—skin cancer	0.000213	0.000764	CcSEcCtD
Mirtazapine—Somnolence—Fluorouracil—skin cancer	0.000213	0.000763	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Temozolomide—skin cancer	0.000212	0.000762	CcSEcCtD
Mirtazapine—Malnutrition—Docetaxel—skin cancer	0.000212	0.000759	CcSEcCtD
Mirtazapine—Hypersensitivity—Dactinomycin—skin cancer	0.000212	0.000759	CcSEcCtD
Mirtazapine—Dyspepsia—Fluorouracil—skin cancer	0.000211	0.000756	CcSEcCtD
Mirtazapine—Decreased appetite—Fluorouracil—skin cancer	0.000208	0.000746	CcSEcCtD
Mirtazapine—Dysgeusia—Docetaxel—skin cancer	0.000207	0.000744	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000207	0.000741	CcSEcCtD
Mirtazapine—Urticaria—Temozolomide—skin cancer	0.000206	0.00074	CcSEcCtD
Mirtazapine—Asthenia—Dactinomycin—skin cancer	0.000206	0.000739	CcSEcCtD
Mirtazapine—Abdominal pain—Temozolomide—skin cancer	0.000205	0.000737	CcSEcCtD
Mirtazapine—Body temperature increased—Temozolomide—skin cancer	0.000205	0.000737	CcSEcCtD
Mirtazapine—Back pain—Docetaxel—skin cancer	0.000205	0.000735	CcSEcCtD
Mirtazapine—Pain—Fluorouracil—skin cancer	0.000205	0.000734	CcSEcCtD
Mirtazapine—Feeling abnormal—Fluorouracil—skin cancer	0.000197	0.000708	CcSEcCtD
Mirtazapine—Diarrhoea—Dactinomycin—skin cancer	0.000196	0.000705	CcSEcCtD
Mirtazapine—Vomiting—Bleomycin—skin cancer	0.000196	0.000702	CcSEcCtD
Mirtazapine—Anaemia—Docetaxel—skin cancer	0.000196	0.000702	CcSEcCtD
Mirtazapine—Rash—Bleomycin—skin cancer	0.000194	0.000697	CcSEcCtD
Mirtazapine—Dermatitis—Bleomycin—skin cancer	0.000194	0.000696	CcSEcCtD
Mirtazapine—Hypersensitivity—Temozolomide—skin cancer	0.000191	0.000687	CcSEcCtD
Mirtazapine—Urticaria—Fluorouracil—skin cancer	0.00019	0.000682	CcSEcCtD
Mirtazapine—Syncope—Docetaxel—skin cancer	0.00019	0.000681	CcSEcCtD
Mirtazapine—Leukopenia—Docetaxel—skin cancer	0.000189	0.00068	CcSEcCtD
Mirtazapine—Body temperature increased—Fluorouracil—skin cancer	0.000189	0.000679	CcSEcCtD
Mirtazapine—Palpitations—Docetaxel—skin cancer	0.000187	0.000671	CcSEcCtD
Mirtazapine—Asthenia—Temozolomide—skin cancer	0.000186	0.000669	CcSEcCtD
Mirtazapine—Loss of consciousness—Docetaxel—skin cancer	0.000186	0.000667	CcSEcCtD
Mirtazapine—Cough—Docetaxel—skin cancer	0.000185	0.000663	CcSEcCtD
Mirtazapine—Pruritus—Temozolomide—skin cancer	0.000184	0.000659	CcSEcCtD
Mirtazapine—Convulsion—Docetaxel—skin cancer	0.000183	0.000658	CcSEcCtD
Mirtazapine—Nausea—Bleomycin—skin cancer	0.000183	0.000656	CcSEcCtD
Mirtazapine—Hypertension—Docetaxel—skin cancer	0.000183	0.000656	CcSEcCtD
Mirtazapine—Vomiting—Dactinomycin—skin cancer	0.000183	0.000655	CcSEcCtD
Mirtazapine—Rash—Dactinomycin—skin cancer	0.000181	0.00065	CcSEcCtD
Mirtazapine—Arthralgia—Docetaxel—skin cancer	0.00018	0.000647	CcSEcCtD
Mirtazapine—Myalgia—Docetaxel—skin cancer	0.00018	0.000647	CcSEcCtD
Mirtazapine—Chest pain—Docetaxel—skin cancer	0.00018	0.000647	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000179	0.000642	CcSEcCtD
Mirtazapine—Diarrhoea—Temozolomide—skin cancer	0.000178	0.000638	CcSEcCtD
Mirtazapine—Hypersensitivity—Fluorouracil—skin cancer	0.000176	0.000633	CcSEcCtD
Mirtazapine—Dry mouth—Docetaxel—skin cancer	0.000176	0.000632	CcSEcCtD
Mirtazapine—Confusional state—Docetaxel—skin cancer	0.000174	0.000625	CcSEcCtD
Mirtazapine—Oedema—Docetaxel—skin cancer	0.000173	0.00062	CcSEcCtD
Mirtazapine—Dizziness—Temozolomide—skin cancer	0.000172	0.000616	CcSEcCtD
Mirtazapine—Infection—Docetaxel—skin cancer	0.000172	0.000616	CcSEcCtD
Mirtazapine—Nausea—Dactinomycin—skin cancer	0.000171	0.000612	CcSEcCtD
Mirtazapine—Shock—Docetaxel—skin cancer	0.00017	0.00061	CcSEcCtD
Mirtazapine—Nervous system disorder—Docetaxel—skin cancer	0.000169	0.000608	CcSEcCtD
Mirtazapine—Pruritus—Fluorouracil—skin cancer	0.000169	0.000608	CcSEcCtD
Mirtazapine—Thrombocytopenia—Docetaxel—skin cancer	0.000169	0.000607	CcSEcCtD
Mirtazapine—Tachycardia—Docetaxel—skin cancer	0.000169	0.000605	CcSEcCtD
Mirtazapine—Skin disorder—Docetaxel—skin cancer	0.000168	0.000602	CcSEcCtD
Mirtazapine—Vomiting—Temozolomide—skin cancer	0.000165	0.000593	CcSEcCtD
Mirtazapine—Anorexia—Docetaxel—skin cancer	0.000165	0.000591	CcSEcCtD
Mirtazapine—Rash—Temozolomide—skin cancer	0.000164	0.000588	CcSEcCtD
Mirtazapine—Diarrhoea—Fluorouracil—skin cancer	0.000164	0.000588	CcSEcCtD
Mirtazapine—Dermatitis—Temozolomide—skin cancer	0.000164	0.000587	CcSEcCtD
Mirtazapine—Headache—Temozolomide—skin cancer	0.000163	0.000584	CcSEcCtD
Mirtazapine—Hypotension—Docetaxel—skin cancer	0.000161	0.000579	CcSEcCtD
Mirtazapine—Dizziness—Fluorouracil—skin cancer	0.000158	0.000568	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000157	0.000565	CcSEcCtD
Mirtazapine—Insomnia—Docetaxel—skin cancer	0.000156	0.000561	CcSEcCtD
Mirtazapine—Paraesthesia—Docetaxel—skin cancer	0.000155	0.000557	CcSEcCtD
Mirtazapine—Nausea—Temozolomide—skin cancer	0.000154	0.000554	CcSEcCtD
Mirtazapine—Dyspnoea—Docetaxel—skin cancer	0.000154	0.000553	CcSEcCtD
Mirtazapine—Somnolence—Docetaxel—skin cancer	0.000154	0.000551	CcSEcCtD
Mirtazapine—Vomiting—Fluorouracil—skin cancer	0.000152	0.000546	CcSEcCtD
Mirtazapine—Dyspepsia—Docetaxel—skin cancer	0.000152	0.000546	CcSEcCtD
Mirtazapine—Rash—Fluorouracil—skin cancer	0.000151	0.000541	CcSEcCtD
Mirtazapine—Dermatitis—Fluorouracil—skin cancer	0.000151	0.000541	CcSEcCtD
Mirtazapine—Decreased appetite—Docetaxel—skin cancer	0.00015	0.000539	CcSEcCtD
Mirtazapine—Headache—Fluorouracil—skin cancer	0.00015	0.000538	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000149	0.000535	CcSEcCtD
Mirtazapine—Fatigue—Docetaxel—skin cancer	0.000149	0.000534	CcSEcCtD
Mirtazapine—Pain—Docetaxel—skin cancer	0.000148	0.00053	CcSEcCtD
Mirtazapine—Constipation—Docetaxel—skin cancer	0.000148	0.00053	CcSEcCtD
Mirtazapine—Feeling abnormal—Docetaxel—skin cancer	0.000142	0.000511	CcSEcCtD
Mirtazapine—Nausea—Fluorouracil—skin cancer	0.000142	0.00051	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Docetaxel—skin cancer	0.000141	0.000507	CcSEcCtD
Mirtazapine—Body temperature increased—Docetaxel—skin cancer	0.000137	0.00049	CcSEcCtD
Mirtazapine—Abdominal pain—Docetaxel—skin cancer	0.000137	0.00049	CcSEcCtD
Mirtazapine—Hypersensitivity—Docetaxel—skin cancer	0.000127	0.000457	CcSEcCtD
Mirtazapine—Asthenia—Docetaxel—skin cancer	0.000124	0.000445	CcSEcCtD
Mirtazapine—Pruritus—Docetaxel—skin cancer	0.000122	0.000438	CcSEcCtD
Mirtazapine—Diarrhoea—Docetaxel—skin cancer	0.000118	0.000424	CcSEcCtD
Mirtazapine—Dizziness—Docetaxel—skin cancer	0.000114	0.00041	CcSEcCtD
Mirtazapine—Vomiting—Docetaxel—skin cancer	0.00011	0.000394	CcSEcCtD
Mirtazapine—Rash—Docetaxel—skin cancer	0.000109	0.000391	CcSEcCtD
Mirtazapine—Dermatitis—Docetaxel—skin cancer	0.000109	0.00039	CcSEcCtD
Mirtazapine—Headache—Docetaxel—skin cancer	0.000108	0.000388	CcSEcCtD
Mirtazapine—Nausea—Docetaxel—skin cancer	0.000103	0.000368	CcSEcCtD
Mirtazapine—ADRA2A—Metabolism—ENO2—skin cancer	1.88e-05	0.000415	CbGpPWpGaD
Mirtazapine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	1.88e-05	0.000414	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—FOXO4—skin cancer	1.87e-05	0.000413	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PTGER4—skin cancer	1.84e-05	0.000407	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PTGER4—skin cancer	1.84e-05	0.000405	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PTCH1—skin cancer	1.83e-05	0.000405	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SMO—skin cancer	1.83e-05	0.000405	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CSPG4—skin cancer	1.8e-05	0.000397	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CSPG4—skin cancer	1.79e-05	0.000394	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PTGER4—skin cancer	1.78e-05	0.000394	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SHH—skin cancer	1.75e-05	0.000387	CbGpPWpGaD
Mirtazapine—HRH3—Signaling by GPCR—HRAS—skin cancer	1.75e-05	0.000386	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—RASA1—skin cancer	1.74e-05	0.000385	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SHH—skin cancer	1.73e-05	0.000381	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SHH—skin cancer	1.72e-05	0.00038	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—RASA1—skin cancer	1.72e-05	0.000379	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—RASA1—skin cancer	1.71e-05	0.000378	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—FOXO4—skin cancer	1.7e-05	0.000376	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SHH—skin cancer	1.69e-05	0.000373	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—RASA1—skin cancer	1.68e-05	0.000371	CbGpPWpGaD
Mirtazapine—HRH3—Signaling by GPCR—IL6—skin cancer	1.68e-05	0.00037	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—FOXO4—skin cancer	1.67e-05	0.000368	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SMO—skin cancer	1.66e-05	0.000367	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTCH1—skin cancer	1.66e-05	0.000367	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTCH1—skin cancer	1.64e-05	0.000361	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SMO—skin cancer	1.64e-05	0.000361	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SMO—skin cancer	1.63e-05	0.000361	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTCH1—skin cancer	1.63e-05	0.000361	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—FOXO4—skin cancer	1.63e-05	0.00036	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—FOXO4—skin cancer	1.62e-05	0.000358	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTGER4—skin cancer	1.62e-05	0.000357	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SMO—skin cancer	1.6e-05	0.000354	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTCH1—skin cancer	1.6e-05	0.000354	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTGER4—skin cancer	1.59e-05	0.000352	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTGER4—skin cancer	1.59e-05	0.000351	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—FOXO4—skin cancer	1.58e-05	0.000348	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SHH—skin cancer	1.57e-05	0.000347	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RASA1—skin cancer	1.56e-05	0.000345	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTGER4—skin cancer	1.56e-05	0.000344	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—NRAS—skin cancer	1.55e-05	0.000341	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CSPG4—skin cancer	1.53e-05	0.000337	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TERT—skin cancer	1.49e-05	0.000329	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ENO2—skin cancer	1.49e-05	0.000329	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SMO—skin cancer	1.49e-05	0.000329	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTCH1—skin cancer	1.49e-05	0.000329	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TERT—skin cancer	1.47e-05	0.000324	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PLIN2—skin cancer	1.46e-05	0.000322	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTGER4—skin cancer	1.45e-05	0.00032	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—FOXO4—skin cancer	1.43e-05	0.000316	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—NRAS—skin cancer	1.41e-05	0.000312	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—FOXO4—skin cancer	1.41e-05	0.000311	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TERT—skin cancer	1.41e-05	0.00031	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—FOXO4—skin cancer	1.4e-05	0.00031	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—FOXO4—skin cancer	1.38e-05	0.000304	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—ERCC2—skin cancer	1.34e-05	0.000297	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TERT—skin cancer	1.34e-05	0.000296	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—KRAS—skin cancer	1.33e-05	0.000294	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—FOXO4—skin cancer	1.28e-05	0.000283	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—NRAS—skin cancer	1.26e-05	0.000277	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—NRAS—skin cancer	1.26e-05	0.000277	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TERT—skin cancer	1.25e-05	0.000276	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—NRAS—skin cancer	1.24e-05	0.000273	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ENO2—skin cancer	1.22e-05	0.00027	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—KRAS—skin cancer	1.22e-05	0.000268	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ENO2—skin cancer	1.21e-05	0.000268	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—NRAS—skin cancer	1.18e-05	0.000261	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—TP53—skin cancer	1.18e-05	0.000261	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—BRAF—skin cancer	1.18e-05	0.000261	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CSPG4—skin cancer	1.18e-05	0.00026	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.17e-05	0.000257	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—BRAF—skin cancer	1.16e-05	0.000257	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TERT—skin cancer	1.14e-05	0.000251	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—HRAS—skin cancer	1.13e-05	0.00025	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—NRAS—skin cancer	1.13e-05	0.00025	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—BRAF—skin cancer	1.11e-05	0.000246	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TERT—skin cancer	1.11e-05	0.000246	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—ERCC2—skin cancer	1.09e-05	0.000241	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TERT—skin cancer	1.09e-05	0.00024	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TERT—skin cancer	1.08e-05	0.000239	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—KRAS—skin cancer	1.08e-05	0.000239	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—TP53—skin cancer	1.08e-05	0.000239	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—KRAS—skin cancer	1.08e-05	0.000239	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—KRAS—skin cancer	1.06e-05	0.000235	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—BRAF—skin cancer	1.06e-05	0.000235	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TERT—skin cancer	1.05e-05	0.000232	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—NRAS—skin cancer	1.05e-05	0.000232	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ENO2—skin cancer	1.04e-05	0.000229	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—HRAS—skin cancer	1.03e-05	0.000228	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—KRAS—skin cancer	1.02e-05	0.000225	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—IL6—skin cancer	9.9e-06	0.000218	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—BRAF—skin cancer	9.89e-06	0.000218	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—KRAS—skin cancer	9.73e-06	0.000215	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—TP53—skin cancer	9.61e-06	0.000212	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—NRAS—skin cancer	9.59e-06	0.000212	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TERT—skin cancer	9.55e-06	0.000211	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.49e-06	0.000209	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TERT—skin cancer	9.4e-06	0.000208	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TERT—skin cancer	9.38e-06	0.000207	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—NRAS—skin cancer	9.38e-06	0.000207	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TERT—skin cancer	9.21e-06	0.000203	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—HRAS—skin cancer	9.19e-06	0.000203	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—HRAS—skin cancer	9.19e-06	0.000203	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—NRAS—skin cancer	9.17e-06	0.000202	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—NRAS—skin cancer	9.12e-06	0.000201	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—KRAS—skin cancer	9.05e-06	0.0002	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—HRAS—skin cancer	9.05e-06	0.0002	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—BRAF—skin cancer	9.01e-06	0.000199	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—NRAS—skin cancer	8.87e-06	0.000196	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—BRAF—skin cancer	8.81e-06	0.000195	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—IL6—skin cancer	8.8e-06	0.000194	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—HRAS—skin cancer	8.66e-06	0.000191	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—IL6—skin cancer	8.66e-06	0.000191	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ERCC2—skin cancer	8.66e-06	0.000191	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—BRAF—skin cancer	8.62e-06	0.00019	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—BRAF—skin cancer	8.57e-06	0.000189	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TERT—skin cancer	8.55e-06	0.000189	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—BRAF—skin cancer	8.34e-06	0.000184	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—IL6—skin cancer	8.29e-06	0.000183	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—HRAS—skin cancer	8.27e-06	0.000183	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—KRAS—skin cancer	8.25e-06	0.000182	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.11e-06	0.000179	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—KRAS—skin cancer	8.07e-06	0.000178	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PTGS2—skin cancer	8.06e-06	0.000178	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—NRAS—skin cancer	8.05e-06	0.000178	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ENO2—skin cancer	8e-06	0.000177	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—NRAS—skin cancer	7.92e-06	0.000175	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—IL6—skin cancer	7.92e-06	0.000175	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—NRAS—skin cancer	7.9e-06	0.000174	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—KRAS—skin cancer	7.89e-06	0.000174	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—KRAS—skin cancer	7.85e-06	0.000173	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—NRAS—skin cancer	7.76e-06	0.000171	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—HRAS—skin cancer	7.7e-06	0.00017	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—KRAS—skin cancer	7.64e-06	0.000169	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—BRAF—skin cancer	7.57e-06	0.000167	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—BRAF—skin cancer	7.45e-06	0.000164	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—BRAF—skin cancer	7.43e-06	0.000164	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—NRAS—skin cancer	7.42e-06	0.000164	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—IL6—skin cancer	7.37e-06	0.000163	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—NRAS—skin cancer	7.31e-06	0.000161	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—BRAF—skin cancer	7.29e-06	0.000161	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—NRAS—skin cancer	7.21e-06	0.000159	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ERCC2—skin cancer	7.11e-06	0.000157	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ERCC2—skin cancer	7.05e-06	0.000156	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—HRAS—skin cancer	7.01e-06	0.000155	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—NRAS—skin cancer	7e-06	0.000154	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—KRAS—skin cancer	6.93e-06	0.000153	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—HRAS—skin cancer	6.86e-06	0.000151	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—KRAS—skin cancer	6.82e-06	0.00015	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—KRAS—skin cancer	6.8e-06	0.00015	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—BRAF—skin cancer	6.77e-06	0.00015	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL6—skin cancer	6.71e-06	0.000148	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—HRAS—skin cancer	6.71e-06	0.000148	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—NRAS—skin cancer	6.68e-06	0.000147	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—KRAS—skin cancer	6.68e-06	0.000147	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—HRAS—skin cancer	6.67e-06	0.000147	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL6—skin cancer	6.57e-06	0.000145	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTGS2—skin cancer	6.54e-06	0.000144	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—HRAS—skin cancer	6.49e-06	0.000143	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL6—skin cancer	6.42e-06	0.000142	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—KRAS—skin cancer	6.39e-06	0.000141	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL6—skin cancer	6.39e-06	0.000141	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—KRAS—skin cancer	6.29e-06	0.000139	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—NRAS—skin cancer	6.21e-06	0.000137	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL6—skin cancer	6.21e-06	0.000137	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—KRAS—skin cancer	6.2e-06	0.000137	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ERCC2—skin cancer	6.02e-06	0.000133	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—KRAS—skin cancer	6.02e-06	0.000133	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—HRAS—skin cancer	5.89e-06	0.00013	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—HRAS—skin cancer	5.79e-06	0.000128	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—HRAS—skin cancer	5.78e-06	0.000128	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—KRAS—skin cancer	5.75e-06	0.000127	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—skin cancer	5.68e-06	0.000125	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HRAS—skin cancer	5.67e-06	0.000125	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NRAS—skin cancer	5.66e-06	0.000125	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—skin cancer	5.64e-06	0.000124	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—skin cancer	5.59e-06	0.000123	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—skin cancer	5.55e-06	0.000122	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NRAS—skin cancer	5.54e-06	0.000122	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—skin cancer	5.53e-06	0.000122	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—skin cancer	5.43e-06	0.00012	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—skin cancer	5.43e-06	0.00012	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NRAS—skin cancer	5.42e-06	0.00012	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NRAS—skin cancer	5.39e-06	0.000119	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—skin cancer	5.35e-06	0.000118	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—skin cancer	5.35e-06	0.000118	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—skin cancer	5.35e-06	0.000118	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—skin cancer	5.27e-06	0.000116	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NRAS—skin cancer	5.24e-06	0.000116	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—skin cancer	5.2e-06	0.000115	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—skin cancer	5.19e-06	0.000115	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—skin cancer	5.12e-06	0.000113	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—skin cancer	5.12e-06	0.000113	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—skin cancer	5.11e-06	0.000113	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—skin cancer	5.05e-06	0.000111	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—skin cancer	4.9e-06	0.000108	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—skin cancer	4.89e-06	0.000108	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—skin cancer	4.87e-06	0.000108	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—skin cancer	4.77e-06	0.000105	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NRAS—skin cancer	4.76e-06	0.000105	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—skin cancer	4.75e-06	0.000105	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NRAS—skin cancer	4.68e-06	0.000103	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—skin cancer	4.68e-06	0.000103	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NRAS—skin cancer	4.67e-06	0.000103	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—skin cancer	4.66e-06	0.000103	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ERCC2—skin cancer	4.65e-06	0.000103	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—skin cancer	4.64e-06	0.000102	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NRAS—skin cancer	4.58e-06	0.000101	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—skin cancer	4.55e-06	0.0001	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—skin cancer	4.51e-06	9.96e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—skin cancer	4.35e-06	9.6e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—skin cancer	4.33e-06	9.56e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—skin cancer	4.26e-06	9.41e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NRAS—skin cancer	4.26e-06	9.4e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—skin cancer	4.24e-06	9.35e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—skin cancer	4.23e-06	9.33e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—skin cancer	4.14e-06	9.14e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—skin cancer	4.14e-06	9.14e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—skin cancer	4.12e-06	9.1e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—skin cancer	4.09e-06	9.03e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—skin cancer	4.05e-06	8.94e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—skin cancer	4.03e-06	8.89e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—skin cancer	4.02e-06	8.87e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—skin cancer	4.01e-06	8.85e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—skin cancer	3.96e-06	8.75e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—skin cancer	3.96e-06	8.75e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—skin cancer	3.94e-06	8.7e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—skin cancer	3.94e-06	8.7e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—skin cancer	3.88e-06	8.56e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—skin cancer	3.83e-06	8.46e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—skin cancer	3.79e-06	8.37e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—skin cancer	3.77e-06	8.33e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—skin cancer	3.67e-06	8.1e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—skin cancer	3.66e-06	8.09e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—skin cancer	3.64e-06	8.03e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—skin cancer	3.61e-06	7.97e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—skin cancer	3.58e-06	7.9e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—skin cancer	3.57e-06	7.88e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—skin cancer	3.5e-06	7.74e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—skin cancer	3.48e-06	7.68e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—skin cancer	3.42e-06	7.56e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—skin cancer	3.42e-06	7.54e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—skin cancer	3.35e-06	7.4e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—skin cancer	3.33e-06	7.35e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—skin cancer	3.28e-06	7.23e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—skin cancer	3.27e-06	7.22e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—skin cancer	3.26e-06	7.19e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—skin cancer	3.21e-06	7.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—skin cancer	3.11e-06	6.87e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—skin cancer	2.98e-06	6.58e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—skin cancer	2.79e-06	6.15e-05	CbGpPWpGaD
